ロード中...
Correction of bleeding in experimental severe hemophilia A by systemic delivery of factor VIII-encoding mRNA
The treatment or prevention of bleeding in patients with hemophilia A relies on replacement therapy with different factor VIII (FVIII)-containing products or on the use of by-passing agents, i.e., activated prothrombin complex concentrates or recombinant activated factor VII. Emerging approaches inc...
保存先:
| 出版年: | Haematologica |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Ferrata Storti Foundation
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7109737/ https://ncbi.nlm.nih.gov/pubmed/31289204 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2018.210583 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|